Sharif, Nadim and Sharif, Nazmul and Khan, Afsana and Halawani, Ibrahim F. and Alzahrani, Fuad M. and Alzahrani, Khalid J. and Díez, Isabel De la Torre and Ramírez-Vargas, Debora L. and Kuc Castilla, Ángel Gabriel and Parvez, Anowar Khasru and Dey, Shuvra Kanti UNSPECIFIED, UNSPECIFIED, UNSPECIFIED, UNSPECIFIED, UNSPECIFIED, UNSPECIFIED, UNSPECIFIED, debora.ramirez@unini.edu.mx, UNSPECIFIED, UNSPECIFIED, UNSPECIFIED (2023) Prevalence and impact of long COVID-19 among patients with diabetes and cardiovascular diseases in Bangladesh. Frontiers in Public Health, 11. ISSN 2296-2565
|
Text
fpubh-11-1222868.pdf Available under License Creative Commons Attribution. Download (2MB) | Preview |
Abstract
Introduction: Co-prevalence of long-COVID-19, cardiovascular diseases and diabetes is one of the major health challenges of the pandemic worldwide. Studies on long-COVID-19 and associated health outcomes are absent in Bangladesh. The main aim of this study was to determine the prevalence and impact of long-COVID-19 on preexisting diabetes and cardiovascular diseases (CVD) on health outcomes among patients in Bangladesh. Methods: We collected data from 3,250 participants in Bangladesh, retrospectively. Multivariable logistic regression model was used to determine the odds ratio between independent and dependent variables. Kaplan-Meier survival curve was used to determine the cumulative survival. Results: COVID-19 was detected among 73.4% (2,385 of 3,250) participants. Acute long-COVID-19 was detected among 28.4% (678 of 2,385) and chronic long-COVID-19 among 71.6% (1,707 of 2,385) patients. CVD and diabetes were found among 32%, and 24% patients, respectively. Mortality rate was 18% (585 of 3,250) among the participants. Co-prevalence of CVD, diabetes and COVID-19 was involved in majority of fatality (95%). Fever (97%), dry cough (87%) and loss of taste and smell (85%) were the most prevalent symptoms. Patients with co-prevalence of CVD, diabetes and COVID-19 had higher risk of fatality (OR: 3.65, 95% CI, 2.79–4.24). Co-prevalence of CVD, diabetes and chronic long-COVID-19 were detected among 11.9% patients. Discussion: Risk of hospitalization and fatality reduced significantly among the vaccinated. This is one of the early studies on long-COVID-19 in Bangladesh.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | long-COVID-19, comorbidity, diabetes, cardiovascular disease, Banglades |
| Subjects: | Subjects > Biomedicine |
| Divisions: | Europe University of Atlantic > Research > Scientific Production Fundación Universitaria Internacional de Colombia > Research > Scientific Production Ibero-american International University > Research > Scientific Production Ibero-american International University > Research > Scientific Production Universidad Internacional do Cuanza > Research > Scientific Production |
| Depositing User: | Sr Bibliotecario |
| Date Deposited: | 31 Oct 2023 09:38 |
| Last Modified: | 31 Oct 2023 09:38 |
| URI: | http://repositorio.funiber.org/id/eprint/9478 |
Actions (login required)
 |
View Item |
